Typically, that means

Biotech startups

Early-stage companies that need scientific rigour behind a platform, a claim, or an investor narrative before it's tested by outside scrutiny.

Growing life-science companies

Organisations scaling past the point where one internal team can hold the full scientific picture, without yet needing a permanent hire for it.

Research-driven organisations

Groups whose credibility depends on the evidence base underneath their work standing up to scrutiny.

Translational research teams

Teams moving findings from model systems toward application, who need the gaps and risks named clearly and early.

Innovation-focused organisations

Teams evaluating emerging technologies or approaches who need to know where the genuine scientific differentiation is.

CROs & consultancies

Organisations that need specialist scientific capacity for a defined project, on a flexible, project-based basis.

The conversations that usually start an engagement

"We need to understand a complex scientific landscape."

Typically the starting point for a Scientific Landscape Report or Technology Mapping engagement.

"We need an independent assessment of the evidence."

Usually leads to a Translational Evidence Brief or Scientific Strategy Review.

"We are developing a new technology and need to understand scientific differentiation."

Often shaped as Competitive Intelligence combined with a Programme or Technology Assessment.

"We need to turn complex science into a clear decision or strategic narrative."

The starting point for scientific presentations, executive summaries, or stakeholder materials.

Start a conversation about your scientific challenge.

There's no fixed intake process — just a direct conversation about what you're facing and whether this is a good fit.